As ‘transformational’ as the internet: Alten adds blockchain initiative

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/matejmo)
(Image: Getty/matejmo)

Related tags: Blockchain, Clinical trial, Technology, Supply chain, Research, Clinical development, Clinical research

Alten Calsoft Labs launches its first initiative for blockchain through its scalable clinical trial platform BioPharma Ledger to address life sciences processes using BlockApps middleware.

The digital solutions and R&D service provider will provide customers with access to blockchain solutions through its BioPharma Ledger. BlockApps, part of the Enterprise Ethereum Alliance, an open source blockchain initiative, will supply the BioPharma Ledger platform with its BlockApps Strato middleware.

Nick Spring, life sciences partner, Alten Calsoft Labs, said in a statement, “Blockchain will introduce us all to a new age of transparency, privacy, and traceability in all aspects of the life sciences as we know them. It is as transformational to pharma, biotech, and medical devices today, as the internet was to communications 20 years ago.”

He added, “Blockchain has the power to fundamentally shift many core processes for drug research and development by increasing patient safety and privacy, improving quality of data, and significantly shortening the length of clinical trials.”

The first to use the new platform is Clinlogix, a global contract research organization (CRO), which will implement BioPharma Ledger into its real-world clinical trials.

Blockchain’s place in clinical research

Boehringer Ingelheim and IBM Canada​ entered a collaboration in February 2019 to test the capabilities of blockchain technology in clinical trial management. At the time, the companies stated that the use of blockchain in clinical trials was expected to improve validity as well as patient recruitment and retention.

Scientist.com also brought blockchain into the clinical research industry with its addition of DataSmart​. The online marketplace’s platform uses proprietary technology to enable pharmaceutical and biotechnology companies to provide supplier information and research data that remains untampered and unaltered.

Alpha Genesis​ and Certara​ have also tapped into ledger technology to employ blockchain platforms for clinical researchers.

 

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Products

View more

Webinars